These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2211440)

  • 41. [Infections caused by Bacteroides fragilis resistant to clindamycin: 2 further cases].
    Andrieu J; Kwantes M; Lapeyrere X; Gardon JD
    Nouv Presse Med; 1978 Feb; 7(7):571-2. PubMed ID: 643586
    [No Abstract]   [Full Text] [Related]  

  • 42. Peritonitis due to a ruptured splenic abscess.
    Pera M; Pera M; Moreno A
    Clin Infect Dis; 1996 Aug; 23(2):399-400. PubMed ID: 8842287
    [No Abstract]   [Full Text] [Related]  

  • 43. Anaerobic infection therapy.
    Giamarellou H
    Int J Antimicrob Agents; 2000 Nov; 16(3):341-6. PubMed ID: 11091059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis.
    Joiner K; Lowe B; Dzink J; Bartlett JG
    J Infect Dis; 1982 Apr; 145(4):561-8. PubMed ID: 7069236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility.
    Hawser SP; Hackel M; Hoban DJ
    J Antimicrob Chemother; 2010 Apr; 65(4):803-4. PubMed ID: 20130025
    [No Abstract]   [Full Text] [Related]  

  • 46. Enzyme-mediated resistance of Bacteroides fragilis to moxalactam.
    Maskell JP; Nasu M
    Lancet; 1981 Mar; 1(8222):733. PubMed ID: 6110951
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies with cefuroxime and cefoxitin.
    Geddes AM; McGhie D; Ball AP; Gould I
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.
    Griffith RS; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1977 May; 11(5):813-6. PubMed ID: 879736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacteroides fragilis resistant to metronidazole after long-term therapy.
    Ingham HR; Eaton S; Venables CW; Adams PC
    Lancet; 1978 Jan; 1(8057):214. PubMed ID: 74641
    [No Abstract]   [Full Text] [Related]  

  • 51. Susceptibility of intestinal anaerobes to new beta-lactam antibiotics.
    Bansal MB; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(4):237-43. PubMed ID: 6744975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ; Thibault M; Duval J
    Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteroides fragilis infections of the urinary tract.
    Garcia JA; Prieto J; Garcia JE; Saenz MC
    J Antimicrob Chemother; 1977 Sep; 3(5):521-2. PubMed ID: 903332
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
    Hackman AS; Wilkins TD
    Antimicrob Agents Chemother; 1975 Aug; 8(2):224-5. PubMed ID: 1180547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli.
    Dezfulian M; Bitar RA; Bartlett JG
    Chemotherapy; 1993; 39(5):355-60. PubMed ID: 8370326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
    Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First Hungarian case of an infection caused by multidrug-resistant Bacteroides fragilis strain.
    Urbán E; Horváth Z; Sóki J; Lázár G
    Anaerobe; 2015 Feb; 31():55-8. PubMed ID: 25285854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
    Nadaud M
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.